financial guidance
Twist Bioscience Shares Fall 17 Percent as Fiscal Q2 Guidance Comes In Below Wall Street Estimates
Twist provided fiscal second quarter revenue guidance of approximately $56.5 million, with $24 million in synbio revenues and $25 million in NGS revenues.
Roche Diagnostics Revenues Essentially Flat in 2022
Molecular lab revenues fell 17 percent during the year, while core lab sales were up 3 percent and point-of-care revenues grew 15 percent.
Thermo Fisher Scientific Clinical Research Business Delivers Strong Results in First Full Year
Premium
Acquired in December 2021, PPD delivered over 20 percent of Thermo Fisher's core organic revenue growth in the fourth quarter and contributed $1.90 billion in revenue.
Abbott Q4 Diagnostics Revenues Fall 26 Percent on Declining COVID-19 Sales
The company announced that its total revenues for the quarter declined 12 percent, while revenues for the full year rose 1 percent.
Danaher Q4 Revenues Rise 3 Percent Despite Difficulties in China
The firm's Life Sciences segment saw 8 percent growth year over year, while the Diagnostics sector rose 3 percent in the quarter.